Fresenius Medical Care Asia Pacific Receives Prestigious ACHS Global Quality Improvement Award
December 21 2021 - 11:09PM
Business Wire
‘WeAudit’ program recognized for excellence
and innovation in enhancing patient care
Fresenius Medical Care, the world’s leading provider of products
and services for individuals with renal diseases, was presented
with the prestigious Australian Council for Healthcare Standards
(ACHS) Global Quality Improvement Award at a virtual ceremony held
on Thursday 25 November. The award was given for the organization’s
successful implementation of an electronic auditing program across
290 of its dialysis clinics in 10 markets across Asia Pacific.
Called ‘WeAudit’, the electronic auditing program, consisting of a
web-based database and application (app), have led to ongoing
improvements to safety and services for patients and staff in the
region.
The ACHS Global Quality Improvement Award recognizes
organizations that use Australian healthcare standards to
strengthen quality improvement frameworks internationally. This
year, there were two joint winners of the award: Fresenius Medical
Care Asia Pacific for their WeAudit program, and Hong Kong Baptist
Hospital for their COVID-19 response submission.
Following the success of a 3-month pilot program in Singapore,
the WeAudit program was initiated in further nine markets over a
2-year period, where it has replaced time- and labor-intensive
manual quality audits with electronic audits that are undertaken
and uploaded from a hand-held device.
Using the new program, each dialysis clinic in the region is
provided with a hand-held tablet where the WeAudit app is
downloaded. The app is then used to upload audit tools from the
WeAudit database. Once uploaded to the app on the tablet, a
credentialed staff member undertakes the audit on the device, with
every dialysis center completing their audit simultaneously. The
content created through the app audits is fed back into the
database, which converts the data into reports and graphs,
depicting the compliance achievements for each clinic. The program
drives compliance and quality, as standards are monitored at every
clinic for every activity audited.
The project has allowed service gaps to be identified while
monitoring compliance and improving the quality of care for
patients. Designed to meet the specific needs of individual markets
and with multi-language support, WeAudit allows data to be more
accessible, accurate, and timely.
The program goes beyond simple auditing functions, providing the
opportunity for data to be used for strategic planning, guiding
business objectives such as appropriate healthcare and financial
planning to priority areas. It has also recognized areas of
conformity and strength within the organization’s services, leading
to best practice sharing across countries, which has led to safer
and improved services for patients and staff.
Mr. Harry de Wit, President & CEO of Fresenius Medical Asia
Pacific, said that the ACHS’ recognition of WeAudit is testament to
the dedications and efforts of Fresenius Medical Care Asia Pacific
to apply international clinical quality principles across its vast
network of dialysis centers in the region whilst remaining
culturally sensitive. “I would like to thank everyone who has made
this award possible, including the clinics and clinical team
members who have worked tirelessly to successfully implement the
program. This award demonstrates our organization’s commitment to
continuous quality improvement and putting our patients at the
center of everything we do – ultimately helping them to lead more
active and productive lives”.
ABOUT THE AUSTRALIAN COUNCIL FOR HEALTHCARE STANDARDS (ACHS)
QUALITY IMPROVEMENT AWARDS
The ACHS Quality Improvement (QI) Awards acknowledge healthcare
organizations that achieve excellence and innovation in clinical
care, organization-wide practice, service delivery, and performance
measurement. The QI Awards provide an opportunity to promote
innovation by recognizing organizations that place patients at the
center of care.
ABOUT FRESENIUS MEDICAL CARE
Fresenius Medical Care is the world's leading provider of
products and services for individuals with renal diseases of which
around 3.7 million patients worldwide regularly undergo dialysis
treatment. Through its network of 4,151 dialysis clinics, Fresenius
Medical Care provides dialysis treatments for approximately 345,000
patients around the globe. Fresenius Medical Care is also the
leading provider of dialysis products such as dialysis machines or
dialyzers. Along with its core business, the Renal Care Continuum,
the Company focuses on expanding in complementary areas and in the
field of critical care. Fresenius Medical Care is listed on the
Frankfurt Stock Exchange (FME) and on the New York Stock Exchange
(FMS).
For more information, please visit the company’s website:
www.freseniusmedicalcare.asia
DISCLAIMER
This release may contain forward-looking statements that are
subject to various risks and uncertainties. Actual results could
differ materially from those described in these forward-looking
statements due to various factors, including, but not limited to,
changes in business, economic and competitive conditions, legal
changes, regulatory approvals, impacts related to the COVID-19
pandemic results of clinical studies, foreign exchange rate
fluctuations, uncertainties in litigation or investigative
proceedings, and the availability of financing. These and other
risks and uncertainties are detailed in Fresenius Medical Care AG
& Co. KGaA's reports filed with the U.S. Securities and
Exchange Commission. Fresenius Medical Care AG & Co. KGaA does
not undertake any responsibility to update the forward-looking
statements in this release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211221005812/en/
Media Dr. Alexandra Villar Vice President Corporate
Communications and Branding Asia Pacific
Fresenius Medical Care 51/F, Sun Hung Kai Centre, 30
Harbour Road Wanchai, Hong Kong
www.freseniusmedicalcare.asia T +61 2 9466 8020
Alexandra.Villar@fmc-asia.com
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Jul 2023 to Jul 2024